Glioblastoma is a dangerous brain cancer known for its quick growth and insensitivity to typical treatments. Investigations are constantly underway to identify new management strategies, and recently, a unique biomarker named LCA168 has emerged as a potential avenue for glioblastoma treatment. LCA168 is a protein that is highly expressed in gliobl